The Drugs Controller General of India (DCGI) has now allowed Serum Institute of India (SII) to resume the previously paused clinical trial of the Oxford COVID-19 vaccine in the country, confirmed a s…
Read More
Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Byindianadmin
Sep 16, 2020